These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8385043)

  • 21. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 22. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 23. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A vaccine.
    Longson PJ
    BMJ; 1992 Oct; 305(6858):888. PubMed ID: 1330143
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men.
    Hess G; Clemens R; Bienzle U; Schönfeld C; Schunck B; Bock HL
    J Med Virol; 1995 May; 46(1):40-2. PubMed ID: 7623005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A redoubtable obstacle to a hepatitis C vaccine.
    Koff RS
    Gastroenterology; 1993 Apr; 104(4):1228-9. PubMed ID: 8385045
    [No Abstract]   [Full Text] [Related]  

  • 27. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects.
    Ackerman Z; Ablin J; Shouval D
    Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537
    [No Abstract]   [Full Text] [Related]  

  • 28. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.
    Nalin DR; Kuter BJ; Brown L; Patterson C; Calandra GB; Werzberger A; Shouval D; Ellerbeck E; Block SL; Bishop R
    J Hepatol; 1993; 18 Suppl 2():S51-5. PubMed ID: 8182275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis A. A health paradox].
    Domínguez Carmona M
    An R Acad Nac Med (Madr); 1993; 110(2):243-74; discussion 275-82. PubMed ID: 8311198
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children.
    Richtmann R; Chaves RL; Mendonça JS; Konichi SR; Mitre HP; Takei K; Dietz K; Flehmig B
    J Med Virol; 1996 Feb; 48(2):147-50. PubMed ID: 8835347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccines released.
    Am J Infect Control; 1995 Jun; 23(3):213. PubMed ID: 7677269
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis A vaccine.
    Cleghorn G
    Qld Nurse; 1995; 14(3):11. PubMed ID: 7568977
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis A vaccine].
    Mussa GC; Borgione S; Mussa F; Silvestro L
    Minerva Pediatr; 1995 Nov; 47(11):439-44. PubMed ID: 8684338
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity of an inactivated hepatitis A vaccine.
    Sjogren MH; Hoke CH; Binn LN; Eckels KH; Dubois DR; Lyde L; Tsuchida A; Oaks S; Marchwicki R; Lednar W
    Ann Intern Med; 1991 Mar; 114(6):470-1. PubMed ID: 1994794
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunisation against hepatitis A--active or passive?
    Iwarson S
    Infection; 1996; 24(1):2-4. PubMed ID: 8852454
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine].
    Noskova AV; Gorbunov MA; Pavlova LI; El'shina GA; Sharipova IS; Karpovich LG; Kalashnikova TI; Bektimirov TA; Rikhmer VV; El'nikov VS
    Vopr Virusol; 2000; 45(6):42-4. PubMed ID: 11200647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.